|
|
Previous Article | Table of Contents | Next Article 
Modulation of Bcl-2 Protein by CD4 Cross-Linking: A Possible Mechanism for Lymphocyte Apoptosis in Human Immunodeficiency Virus Infection and for Rescue of Apoptosis by Interleukin-2
Futoshi Hashimoto,
Naoki Oyaizu,
Vaniambadi S. Kalyanaraman, and
Savita Pahwa
From the Department of Pediatrics, North Shore University Hospital-New York University School of Medicine, Manhasset, NY and Advanced BioScience Laboratories, Inc, Kensington, MD.
We have previously demonstrated that CD4 cross-linking (CD4XL) results in apoptosis of CD4+ T cells and augmentation of Fas antigen (CD95, APO-1) expression in CD4+ and CD8+ T cells. Here we demonstrate that CD4XL mediated by both, anti-CD4 monoclonal antibody (MoAb) or human immunodeficiency virus (HIV) envelope protein gp120 reduces the expression of the proto-oncogene Bcl-2 in CD4+ T cells, but not in CD8+ T cells, concurrently with the induction of CD4+ T cell-apoptosis. Additionally, the Bcl-2dim population expressed high levels of Fas antigen. Bax, an antagonist of Bcl-2, was brightly expressed even in the Bcl-2dim population. Addition of interleukin (IL)-2 rescued CD4+ T cells from CD4XL-induced Bcl-2 downmodulation and apoptosis induction. These results support the hypothesis that CD4 ligation by HIV-1 envelope protein in vivo in HIV-infected patients selectively reduces Bcl-2 protein in CD4+ T lymphocytes, thereby facilitating Fas/Fas-ligand triggered apoptosis; furthermore the findings reported expand the rationale for use of IL-2 in HIV disease.
Blood, Vol. 90 No. 2 (July 15), 1997:
pp. 745-753
© 1997 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. A. Rider, C. E.G. Havenith, R. de Ridder, J. Schuurman, C. Favre, J. C. Cooper, S. Walker, O. Baadsgaard, S. Marschner, J. G.J. vandeWinkel, et al.
A Human CD4 Monoclonal Antibody for the Treatment of T-Cell Lymphoma Combines Inhibition of T-Cell Signaling by a Dual Mechanism with Potent Fc-Dependent Effector Activity
Cancer Res.,
October 15, 2007;
67(20):
9945 - 9953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Trushin, A. Algeciras-Schimnich, S. R. Vlahakis, G. D. Bren, S. Warren, D. J. Schnepple, and A. D. Badley
Glycoprotein 120 Binding to CXCR4 Causes p38-Dependent Primary T Cell Death That Is Facilitated by, but Does Not Require Cell-Associated CD4
J. Immunol.,
April 15, 2007;
178(8):
4846 - 4853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Gulow, M. Kaminski, K. Darvas, D. Suss, M. Li-Weber, and P. H. Krammer
HIV-1 Trans-Activator of Transcription Substitutes for Oxidative Signaling in Activation-Induced T Cell Death
J. Immunol.,
May 1, 2005;
174(9):
5249 - 5260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zhang, C. J. Fichtenbaum, D. A. Hildeman, J. D. Lifson, and C. Chougnet
CD40 Ligand Dysregulation in HIV Infection: HIV Glycoprotein 120 Inhibits Signaling Cascades Upstream of CD40 Ligand Transcription
J. Immunol.,
February 15, 2004;
172(4):
2678 - 2686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chougnet
Role of CD40 Ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells
J. Leukoc. Biol.,
November 1, 2003;
74(5):
702 - 709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Laub, R. Brecht, M. Dorsch, U. Valey, K. Wenk, and F. Emmrich
Anti-Human CD4 Induces Peripheral Tolerance in a Human CD4+, Murine CD4-, HLA-DR+ Advanced Transgenic Mouse Model
J. Immunol.,
September 15, 2002;
169(6):
2947 - 2955.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nakamoto, S. Kaneko, and K. Kobayashi
Increased susceptibility to apoptosis and attenuated Bcl-2 expression in T lymphocytes and monocytes from patients with advanced chronic hepatitis C
J. Leukoc. Biol.,
July 1, 2002;
72(1):
49 - 55.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Badley, A. A. Pilon, A. Landay, and D. H. Lynch
Mechanisms of HIV-associated lymphocyte apoptosis
Blood,
November 1, 2000;
96(9):
2951 - 2964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Ullrich, J. E. Groopman, and R. K. Ganju
HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases
Blood,
August 15, 2000;
96(4):
1438 - 1442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Somma, L. Tuosto, M. S. G. Montani, M. M. Di Somma, E. Cundari, and E. Piccolella
Engagement of CD4 Before TCR Triggering Regulates Both Bax- and Fas (CD95)-Mediated
J. Immunol.,
May 15, 2000;
164(10):
5078 - 5087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Rawlings, G. M. Crooks, D. Bockstoce, L. W. Barsky, R. Parkman, and K. I. Weinberg
Spontaneous Apoptosis in Lymphocytes From Patients With Wiskott-Aldrich Syndrome: Correlation of Accelerated Cell Death and Attenuated Bcl-2 Expression
Blood,
December 1, 1999;
94(11):
3872 - 3882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Cutrona, N. Leanza, M. Ulivi, G. Melioli, V. L. Burgio, G. Mazzarello, G. Gabutti, S. Roncella, and M. Ferrarini
Expression of CD10 by Human T Cells That Undergo Apoptosis Both In Vitro and In Vivo
Blood,
November 1, 1999;
94(9):
3067 - 3076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gaubin, M. Autiero, S. Basmaciogullari, D. Metivier, Z. Misehal, R. Culerrier, A. Oudin, J. Guardiola, and D. Piatier-Tonneau
Potent Inhibition of CD4/TCR-Mediated T Cell Apoptosis by a CD4-Binding Glycoprotein Secreted from Breast Tumor and Seminal Vesicle Cells
J. Immunol.,
March 1, 1999;
162(5):
2631 - 2638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Moutouh, J. Estaquier, D. D. Richman, and J. Corbeil
Molecular and Cellular Analysis of Human Immunodeficiency Virus-Induced Apoptosis in Lymphoblastoid T-Cell-Line-Expressing Wild-Type and Mutated CD4 Receptors
J. Virol.,
October 1, 1998;
72(10):
8061 - 8072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tinhofer, I. Marschitz, M. Kos, T. Henn, A. Egle, A. Villunger, and R. Greil
Differential Sensitivity of CD4+ and CD8+ T Lymphocytes to the Killing Efficacy of Fas (Apo-1/CD95) Ligand+ Tumor Cells in B Chronic Lymphocytic Leukemia
Blood,
June 1, 1998;
91(11):
4273 - 4281.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|